“Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 4-Year Analysis of the KEEPsAKE 1 and 2 Trials”, J of Skin, vol. 8, no. 6, p. s444, Nov. 2024, doi: 10.25251/skin.8.supp.444.